nach oben

Erschienen in:

18.08.2023 | Main topic

Computed tomography to guide transcatheter aortic valve implantation

verfasst von: Marwa Daghem, Florian Weidinger, Professor Dr. med. Stephan Achenbach

Erschienen in: Herz | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Since its introduction in 2022, transcatheter aortic valve implantation (TAVI) has revolutionized the treatment and prognosis of patients with aortic stenosis. Robust clinical trial data and a wealth of scientific evidence support its efficacy and safety. One of the key factors for success of the TAVI procedure is careful preprocedural planning using imaging. Computed tomography (CT) has developed into the standard imaging method for comprehensive patient assessment in this context. Suitability of the femoral and iliac arteries for transfemoral access, exact measurement of aortic annulus size and geometry as the basis for prosthesis selection, quantification of the spatial relationship of the coronary ostia to the aortic annular plane, and identification of optimal fluoroscopic projection angles for the implantation procedure are among the most important information that can be gained from preprocedural CT. Further research is aimed at improving risk stratification, for example, with respect to annular perforation, periprosthetic aortic regurgitation, and need for postprocedural implantation of a permanent pacemaker.

Mack MJ, Leon MB, Thourani VH et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695–1705. https://doi.org/10.1056/nejmoa1814052CrossRefPubMed

Popma JJ, Deeb GM, Yakubov SJ et al (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380:1706–1715. https://doi.org/10.1056/nejmoa1816885CrossRefPubMed

Investigators TUTT, Fairbairn T, Kemp I et al (2022) Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. JAMA 327:1875–1887. https://doi.org/10.1001/jama.2022.5776CrossRef

Vahanian A, Beyersdorf F, Praz F et al (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease. EuroIntervention 17:e1126–e1196. https://doi.org/10.4244/eij-e-21-00009CrossRefPubMedPubMedCentral

Ali N, Faour A, Rawlins J et al (2021) ‘Valve for life’: tackling the deficit in transcatheter treatment of heart valve disease in the UK. Open Heart 8:e1547. https://doi.org/10.1136/openhrt-2020-001547CrossRefPubMedPubMedCentral

Achenbach S, Delgado V, Hausleiter J et al (2012) SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 6:366–380. https://doi.org/10.1016/j.jcct.2012.11.002CrossRefPubMed

Tops LF, Wood DA, Delgado V et al (2008) Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 1:321–330. https://doi.org/10.1016/j.jcmg.2007.12.006CrossRefPubMed

Toggweiler S, Gurvitch R, Leipsic J et al (2012) Percutaneous aortic valve replacement vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 59:113–118. https://doi.org/10.1016/j.jacc.2011.08.069CrossRefPubMed

Wiewiórka Ł, Trębacz J, Sobczyński R et al (2023) Computed tomography guided tailored approach to transfemoral access in patients undergoing transcatheter aortic valve implantation. Cardiol J 30:51–58. https://doi.org/10.5603/cj.a2021.0053CrossRefPubMedPubMedCentral

10.

Harries I, Weir-McCall JR, Williams MC et al (2020) CT imaging prior to transcatheter aortic valve implantation in the UK. Open Heart 7:e1233. https://doi.org/10.1136/openhrt-2019-001233CrossRefPubMedPubMedCentral

11.

Blanke P, Weir-McCall JR, Achenbach S et al (2019) Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) / transcatheter aortic valve replacement (TAVR): an expert consensus document of the society of cardiovascular computed tomography. J Cardiovasc Comput 13:1–20. https://doi.org/10.1016/j.jcct.2018.11.008CrossRef

12.

Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143:e72–e227. https://doi.org/10.1161/cir.0000000000000923CrossRefPubMed

13.

Vahanian A, Beyersdorf F, Praz F et al (2021) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43:561–632. https://doi.org/10.1093/eurheartj/ehab395CrossRef

14.

van Kesteren F, van Mourik MS, Vendrik J et al (2018) Incidence, predictors, and impact of vascular complications after transfemoral transcatheter aortic valve implantation with the SAPIEN 3 prosthesis. Am J Cardiol 121:1231–1238. https://doi.org/10.1016/j.amjcard.2018.01.050CrossRefPubMed

15.

Batchelor W, Patel K, Hurt J et al (2020) Incidence, prognosis and predictors of major vascular complications and percutaneous closure device failure following contemporary percutaneous ransfemoral transcatheter aortic valve replacement. Cardiovasc Revasc Med 21:1065–1073. https://doi.org/10.1016/j.carrev.2020.01.007CrossRefPubMedPubMedCentral

16.

Mach M, Poschner T, Hasan W et al (2021) The Iliofemoral tortuosity score predicts access and bleeding complications during transfemoral transcatheter aortic valve replacement: data from the VIenna cardio thoracic aOrtic valve registrY (VICTORY). Eur J Clin Invest 51:e13491. https://doi.org/10.1111/eci.13491CrossRefPubMedPubMedCentral

17.

Okuyama K, Jilaihawi H, Kashif M et al (2015) Transfemoral Access Assessment for Transcatheter Aortic Valve Replacement: Evidence-Based Application of Computed Tomography Over Invasive Angiography. Circ Cardiovasc Imaging. https://doi.org/10.1161/circimaging.114.001995CrossRefPubMed

18.

Blanke P, Weir-McCall JR, Achenbach S et al (2019) Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI)/Transcatheter aortic valve replacement (TAVR). JACC Cardiovasc Imaging 12:1–24. https://doi.org/10.1016/j.jcmg.2018.12.003CrossRefPubMed

19.

Blakeslee-Carter J, Dexter D, Mahoney P et al (2018) A novel Iliac morphology score predicts procedural mortality and major vascular complications in transfemoral aortic valve replacement. Ann Vasc Surg 46:208–217. https://doi.org/10.1016/j.avsg.2017.06.137CrossRefPubMed

20.

Staniloae CS, Jilaihawi H, Amoroso NS et al (2019) Systematic transfemoral transarterial transcatheter aortic valve replacement in hostile vascular access. Struct Heart 3:34–40. https://doi.org/10.1080/24748706.2018.1556828CrossRef

21.

Patel JS, Krishnaswamy A, Svensson LG et al (2016) Access options for transcatheter aortic valve replacement in patients with unfavorable aortoiliofemoral anatomy. Curr Cardiol Rep 18:110. https://doi.org/10.1007/s11886-016-0788-8CrossRefPubMed

22.

Lederman RJ, Greenbaum AB, Rogers T et al (2017) Anatomic suitability for transcaval access based on computed tomography. JACC Cardiovasc Interv 10:1–10. https://doi.org/10.1016/j.jcin.2016.09.002CrossRefPubMedPubMedCentral

23.

Jilaihawi H, Kashif M, Fontana G et al (2012) Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 59:1275–1286. https://doi.org/10.1016/j.jacc.2011.11.045CrossRefPubMed

24.

Murphy DT, Blanke P, Alaamri S et al (2016) Dynamism of the aortic annulus: effect of diastolic versus systolic CT annular measurements on device selection in transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 10:37–43. https://doi.org/10.1016/j.jcct.2015.07.008CrossRefPubMed

25.

Schuhbaeck A, Achenbach S, Pflederer T et al (2014) Reproducibility of aortic annulus measurements by computed tomography. Eur Radiol 24:1878–1888. https://doi.org/10.1007/s00330-014-3199-5CrossRefPubMed

26.

Schmidkonz C, Marwan M, Klinghammer L et al (2014) Interobserver variability of CT angiography for evaluation of aortic annulus dimensions prior to transcatheter aortic valve implantation (TAVI). Eur J Radiol 83:1672–1678. https://doi.org/10.1016/j.ejrad.2014.06.001CrossRefPubMed

27.

Leipsic J, Gurvitch R, LaBounty TM et al (2011) Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging 4:416–429. https://doi.org/10.1016/j.jcmg.2011.01.014CrossRefPubMed

28.

Ribeiro HB, Webb JG, Makkar RR et al (2013) Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation insights from a large multicenter registry. J Am Coll Cardiol 62:1552–1562. https://doi.org/10.1016/j.jacc.2013.07.040CrossRefPubMed

29.

Akinseye OA, Jha SK, Ibebuogu UN (2018) Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement: a systematic review. Cardiovasc Revasc Med 19:229–236. https://doi.org/10.1016/j.carrev.2017.09.006CrossRefPubMed

30.

Heitkemper M, Hatoum H, Azimian A et al (2020) Modeling risk of coronary obstruction during transcatheter aortic valve replacement. J Thorac Cardiovasc Surg 159:829–838.e3. https://doi.org/10.1016/j.jtcvs.2019.04.091CrossRefPubMed

31.

Lederman RJ, Babaliaros VC, Rogers T et al (2019) Preventing coronary obstruction during transcatheter aortic valve replacement. JACC Cardiovasc Interv 12:1197–1216. https://doi.org/10.1016/j.jcin.2019.04.052CrossRefPubMedPubMedCentral

32.

Seiffert M, Fujita B, Avanesov M et al (2016) Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices. Eur Heart J Cardiovasc Imaging 17:576–584. https://doi.org/10.1093/ehjci/jev174CrossRefPubMed

33.

Musallam A, Buchanan KD, Yerasi C et al (2022) Impact of left ventricular outflow tract calcification on outcomes following transcatheter aortic valve replacement. Cardiovasc Revasc Med 35:1–7. https://doi.org/10.1016/j.carrev.2021.07.010CrossRefPubMed

34.

Hansson NC, Nørgaard BL, Barbanti M et al (2015) The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr 9:382–392. https://doi.org/10.1016/j.jcct.2015.04.002CrossRefPubMed

35.

Okuno T, Asami M, Heg D et al (2020) Impact of left ventricular outflow tract calcification on procedural outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv 13:1789–1799. https://doi.org/10.1016/j.jcin.2020.04.015CrossRefPubMed

36.

Jilaihawi H, Makkar RR, Kashif M et al (2014) A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 15:1324–1332. https://doi.org/10.1093/ehjci/jeu162CrossRefPubMed

37.

Hokken TW, Muhemin M, Okuno T et al (2022) Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: the INTERSECT registry. J Cardiovasc Comput Tomogr 16:524–530. https://doi.org/10.1016/j.jcct.2022.07.003CrossRefPubMed

38.

Mauri V, Deuschl F, Frohn T et al (2018) Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device. Clin Res Cardiol 107:688–697. https://doi.org/10.1007/s00392-018-1235-1CrossRefPubMed

39.

Mauri V, Reimann A, Stern D et al (2016) Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv 9:2200–2209. https://doi.org/10.1016/j.jcin.2016.08.034CrossRefPubMed

40.

Hamdan A, Guetta V, Klempfner R et al (2015) Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv 8:1218–1228. https://doi.org/10.1016/j.jcin.2015.05.010CrossRefPubMed

41.

Makkar RR, Yoon S‑H, Chakravarty T et al (2021) Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke among patients at low surgical risk. JAMA 326:1034–1044. https://doi.org/10.1001/jama.2021.13346CrossRefPubMedPubMedCentral

42.

Roberts WC, Janning KG, Ko JM et al (2012) Frequency of congenitally bicuspid aortic valves in patients ≥80 years of age undergoing aortic valve replacement for aortic stenosis (with or without aortic regurgitation) and implications for transcatheter aortic valve implantation. Am J Cardiol 109:1632–1636. https://doi.org/10.1016/j.amjcard.2012.01.390CrossRefPubMed

43.

Montalto C, Sticchi A, Crimi G et al (2021) Outcomes after transcatheter aortic valve replacement in bicuspid versus tricuspid anatomy a systematic review and meta-analysis. JACC Cardiovasc Interv 14:2144–2155. https://doi.org/10.1016/j.jcin.2021.07.052CrossRefPubMed

44.

Keane MG, Wiegers SE, Plappert T et al (2000) Bicuspid Aortic Valves Are Associated With Aortic Dilatation Out of Proportion to Coexistent Valvular Lesions. Circulation. https://doi.org/10.1161/circ.102.suppl_3.iii-35CrossRefPubMed

45.

Holfeld J, Nägele F, Stoessel L et al (2022) Different calcification patterns of tricuspid and bicuspid aortic valves and their clinical impact. Thorac Cardiovasc Surg 70:S1–S61. https://doi.org/10.1055/s-0042-1742938CrossRef

46.

Frangieh AH, Michel J, Deutsch O et al (2019) Aortic annulus sizing in stenotic bicommissural non-raphe-type bicuspid aortic valves: reconstructing a three-dimensional structure using only two hinge points. Clin Res Cardiol 108:6–15. https://doi.org/10.1007/s00392-018-1295-2CrossRefPubMed

47.

Schäfers H‑J, Schmied W, Marom G, Aicher D (2012) Cusp height in aortic valves. J Thorac Cardiovasc Surg 146:269–274. https://doi.org/10.1016/j.jtcvs.2012.06.053CrossRefPubMed

48.

Goudot G, Mirault T, Rossi A et al (2019) Segmental aortic stiffness in patients with bicuspid aortic valve compared with first-degree relatives. Heart 105:130. https://doi.org/10.1136/heartjnl-2018-313232CrossRefPubMed

49.

Emam ARA, Chamsi-Pasha M, Pavlides G (2016) Ostial coronary occlusion during TAVR in bicuspid aortic valve, should we redefine what is a safe ostial height? Int J Cardiol 212:288–289. https://doi.org/10.1016/j.ijcard.2016.03.100CrossRefPubMed

50.

Alkadhi H, Leschka S, Trindade PT et al (2010) Cardiac CT for the differentiation of bicuspid and tricuspid aortic valves: comparison with echocardiography and surgery. Am J Roentgenol 195:900–908. https://doi.org/10.2214/ajr.09.3813CrossRef

51.

Tanaka R, Yoshioka K, Niinuma H et al (2010) Diagnostic value of cardiac CT in the evaluation of bicuspid aortic stenosis: comparison with echocardiography and operative findings. Am J Roentgenol 195:895–899. https://doi.org/10.2214/ajr.09.3164CrossRef

52.

Sievers H‑H, Schmidtke C (2007) A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg 133:1226–1233. https://doi.org/10.1016/j.jtcvs.2007.01.039CrossRefPubMed

53.

Yoon S‑H, Kim W‑K, Dhoble A et al (2020) Bicuspid aortic valve morphology and outcomes after transcatheter aortic valve replacement. J Am Coll Cardiol 76:1018–1030. https://doi.org/10.1016/j.jacc.2020.07.005CrossRefPubMed

54.

Tam DY, Dharma C, Rocha RV et al (2020) Transcatheter ViV versus redo surgical AVR for the management of failed biological prosthesis early and late outcomes in a propensity-matched cohort. JACC Cardiovasc Interv 13:765–774. https://doi.org/10.1016/j.jcin.2019.10.030CrossRefPubMed

55.

Webb JG, Murdoch DJ, Alu MC et al (2019) 3‑year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses the PARTNER 2 registry. J Am Coll Cardiol 73:2647–2655. https://doi.org/10.1016/j.jacc.2019.03.483CrossRefPubMed

56.

Dvir D, Webb JG, Bleiziffer S et al (2014) Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 312:162–170. https://doi.org/10.1001/jama.2014.7246CrossRefPubMed

57.

Ochiai T, Oakley L, Sekhon N et al (2020) Risk of coronary obstruction due to sinus sequestration in redo transcatheter aortic valve replacement. JACC Cardiovasc Interv 13:2617–2627. https://doi.org/10.1016/j.jcin.2020.09.022CrossRefPubMed

58.

Ribeiro HB, Rodés-Cabau J, Blanke P et al (2017) Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J 39:687–695. https://doi.org/10.1093/eurheartj/ehx455CrossRef

59.

Dvir D, Leipsic J, Blanke P et al (2015) Coronary Obstruction in Transcatheter Aortic Valve-in-Valve Implantation: Preprocedural Evaluation, Device Selection, Protection, and Treatment. Circ Cardiovasc Interv. https://doi.org/10.1161/circinterventions.114.002079CrossRefPubMed

Titel: Computed tomography to guide transcatheter aortic valve implantation
verfasst von: Marwa Daghem
Florian Weidinger
Professor Dr. med. Stephan Achenbach
Publikationsdatum: 18.08.2023
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe 5/2023
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-023-05203-4

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Computed tomography to guide transcatheter aortic valve implantation

Abstract

Neu im Fachgebiet Kardiologie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2023

Kardiale Bildgebung – mehr als reine Diagnostik

Kardiovaskuläre Therapie bei chronischer Nierenerkrankung

Koronare CT-Angiographie und koronare Atherosklerose

Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions

Comparison of outcomes between single long stent and overlapping stents: a meta-analysis of the literature

Atrial fibrillation increases the risk of new-onset myocardial infarction amongst working-age population: a propensity-matched study

Neu im Fachgebiet Kardiologie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie